UPCOMING SUBMISSION DEADLINES
2024 AWARDS ARE OPEN FOR APPLICATION
Friday, 15th December 2023
Submit your applications for the Obesity Prize for Excellence or the New Investigator Awards in Basic Science, Clinical Research, Childhood Obesity or Public Health.
ABSTRACT SUBMISSION FOR #ECO2024 IS OPEN
January 14th 2024
We invite you to share your high quality research and clinical work. E-posters will form an important part of the 31st European Congress on Obesity.
ECN Board member Dr Cilius Fonvig invites qualified New Investigators across disciplines to apply for this excellent grant award opportunity.
SAVE THE DATE #ECO2024
The 31st European Congress on Obesity (#ECO2024) will take place 12-15 May 2024 in Venice, Italy. Mark your calendars for this premier obesity event; register and secure accommodation early to avoid disappointment.
We look forward to hosting you in Venice!
EASO EARLY CAREER NETWORK WEBINAR
Understanding Patient & Public Involvement in Obesity Research featuring Mr Ken Clare & Professor Louisa Ells
Tuesday 21st November 2023
(4:00pm-5:00pmUK / 5:00pm-6:00pmParis)
The EASO Early Career Network (ECN) invites all ECN members to attend the final eLearning Hub online event of 2023. Audience members will gain insights into practical strategies and methods for incorporating PPI into obesity research
Join the ECN network
EASO COMs Webinar
Women’s Health and Obesity: Pregnancy, Fertility and Polycystic Ovary Syndrome (PCOS)
Tuesday 28th November 2023
(11:30am-12:30pm UK / 12:30-1:30pm Paris)
In this 1-hour webinar, two expert clinicians in obesity will explore important clinical areas in women’s health: pregnancy and fertility
Overcoming Policy Barriers to Improving Care for People with Obesity: Adding Value in Health
On 26 October EASO, in collaboration with the MEP Interest Group on Obesity and Health Systems Resilience, convened a technical working session to discuss overcoming policy barriers to improving care for people with obesity, adding value in health across the EU
Patient Warning: Counterfeit Obesity Medication
Counterfeit obesity medication is putting the lives of patients at risk. The new generation of obesity medications is expensive and in short supply, which has created a global surge in black market sales of counterfeit versions of these drugs
Global Support for World Obesity Federation Position Statement
The statement, titled “Changing the Global Obesity Narrative to Recognize and Reduce Weight Stigma,” was published in Obesity Reviews and is available open access here.
Insights from Romania: The 2023 ARSO National Congress
EASO and ECPO colleagues were delighted this week to participate in the national congress of the EASO Romanian membership association
CECON 2023: New Horizons in Obesity Management
The 9th Central European Congress on Obesity was held at the Vienna House Diplomat in Prague, capital of the Czech Republic, 13–14 October 2023, covering a wide range of topics
Introducing EASO Early Career Network Member Elwira Gliwska
Elwira Gliwska is a dietitian and public health specialist in Poland and a member of the EASO Early Career Network. Elwira has participated in an EASO Obesity Masterclass and in the 2022 EASO Early Career Network Winter School in Seville
16th European Public Health (EPH) Conference
8 – 11 November in Dublin, Ireland
14th European Nutrition Conference FENS 2023
14 – 17th November in Belgrade, Serbia
SEEDO 2023: XIX Congreso Nacional
22-25 November in Sevilla Spain
2024 Nordic Obesity Meeting will take place 1–3 February 2024 in Helsinki, Finland.
Abstract submission deadline: 14th September
1-3 February 2024 in Helsinki, Finland
EASL Liver Cancer Summit 2024
22–24 Feb. 2024 in Rotterdam, Netherlands, and online
Abstract Submission Deadline 21st November 2023
OBESITY FACTS JOURNAL
Read the latest edition of OBESITY FACTS, THE EUROPEAN JOURNAL OF OBESITY
Volume 16, Issue 5, online first articles are all available open access.
- Obesity Paradox in Lung Diseases: What Explains It?
- Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population
- Obesity Paradox in Lung Diseases: What Explains It?
- Frequency and Functional Consequences of Low Appendicular Lean Mass and Sarcopenic Obesity in Patients with Asthma Referred for Pulmonary Rehabilitation
- Efficacy of Intragastric Balloon versus Liraglutide as Bridge to Surgery in Super-Obese Patients
- Correlates of Food Addiction and Eating Behaviours in Patients with Morbid Obesity
- Evaluating the Impact of Obesity and Different Metabolic Statuses on the Prognosis of Hospitalized Patients with Inflammatory Bowel Disease: A Cohort Study
- Bibliometric and Correlation Analysis of Bariatric Surgery Researches in Asia-Pacific from 2000 to 2021
- Higher Sensitivity to Thyroid Hormones May Be Linked to Maintaining the Healthy Metabolic Condition in People with Obesity: New Insight from NHANES
- Usefulness of an Easy, Structured, and Home-Based Exercise Program to Improve Physical Performance and Quality of Life in a Patient’s Cohort with Obesity
- The Narrative of a Patient with Leptin Receptor Deficiency: Personalized Medicine for a Rare Genetic Obesity Disorder
Did you know? Sweeteners Can Replace the Sweet Taste of Sugar with a Lower Environmental Impact
Consuming too much-added sugar is not just a health issue but is also a concern for our environment.
Non-nutritive sweeteners (NNSs), like aspartame and neotame, may offer a solution. Although health issues around alternate sweeteners are often discussed, their environmental impacts have been less explored.
This groundbreaking study looks into the environmental effects of these sweeteners, marking the first-ever analysis of neotame’s footprint.
Introducing Bio-Streams: Addressing Childhood and Adolescent Obesity in the EU
Bio-Streams, a new Horizon Europe Research and Innovation project designed to address the growing epidemic of underage obesity in the European Union, is excited to announce its official launch.
This groundbreaking project combines data-driven research, prevention measures and community participation to provide a holistic approach to reducing obesity rates among children and adolescents.
Obesity is a chronic relapsing disease that acts as a gateway to other NCDs and is linked with an increased risk of developing breast, ovary, liver and colon cancer.
EASO is pleased to support the European Cancer Organisation-led Interact Europe project, which brings together 33 partners from 17 countries to develop a patient-centred European inter-specialty cancer training programme.
Proactive Strategies for Addressing Childhood Obesity and reducing Future Cancer Risks
EASO is delighted to partner with the European Health Management Association in a new project, PREVENT — improving and upscaling primary prevention of cancer by addressing childhood obesity through implementation research.
EASO is pleased to support this 5 year EU funded H2020 initiative. TIMESPAN, led by scientific coordinator Professor Henrik Larsson (Örebro University), includes 17 partners from across academia, industry, and patient advocacy communities, and aims to foster improvement in clinical management of adults living with with ADHD and co-occurring cardiometabolic disease, including obesity.